Stay updated on Phase 2 AMEERA-4 Clinical Trial
Sign up to get notified when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.

Latest updates to the Phase 2 AMEERA-4 Clinical Trial page
- Check3 days agoChange DetectedA banner announces NIH website transition updates and says “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision: v3.7.0 is displayed on the page, indicating the current revision of the record. This appears to be a routine update and does not modify the study details or documents shown.SummaryDifference18%

- Check59 days agoChange DetectedAdded NIH grant/contract identifier 2019 under Other Study IDs. Updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag was updated to v3.6.5. The prior v3.6.4 tag was removed along with non-core content such as the Plain Language Results Summary, sponsor label, and the Helpful Links Provided by line.SummaryDifference0.2%

Stay in the know with updates to Phase 2 AMEERA-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 AMEERA-4 Clinical Trial page.